Author Interviews, Cannabis, Diabetes / 16.09.2025
EASD 25: Boston University Study Finds Cannabis Use Carries Risk of Type 2 Diabetes
[caption id="attachment_70686" align="alignleft" width="150"]
Dr. Kamel[/caption]
MedicalResearch.com Interview with:
Ibrahim Kamel, MD, MHA
Boston Medical Center – Brighton
Clinical Instructor
Boston Medical Center
Boston University
MedicalResearch.com: What is the background for this study?
Response: Cannabis use carries risk for developing Type 2 diabetes. It is important for physicians to screen for the use of cannabis to better understand each patients risk.
MedicalResearch.com: What are the main findings?
Response: Clinically physicians should screen for and council on the risk of cannabis use. People should know what is the risk in the substances they use and make the choice that they feel is right.
Dr. Kamel[/caption]
MedicalResearch.com Interview with:
Ibrahim Kamel, MD, MHA
Boston Medical Center – Brighton
Clinical Instructor
Boston Medical Center
Boston University
MedicalResearch.com: What is the background for this study?
Response: Cannabis use carries risk for developing Type 2 diabetes. It is important for physicians to screen for the use of cannabis to better understand each patients risk.
MedicalResearch.com: What are the main findings?
Response: Clinically physicians should screen for and council on the risk of cannabis use. People should know what is the risk in the substances they use and make the choice that they feel is right.
Dr. Goldman[/caption]
Anna L. Goldman, M.D., M.P.A., M.P.H
Assistant Professor of Medicine
General Internal Medicine
Dr. Rowe[/caption]
Susannah G. Rowe, MD, MPH
Office of Equity, Vitality and Inclusion
Boston University Medical Group
Boston Medical Center
Boston University School of Medicine
Boston, Massachusetts
MedicalResearch.com: What is the background for this study?
Response: We wanted to learn how frequently mistreatment occurs for clinicians at work and how it impacts their occupational well-being. We began to see more anecdotal reports of workplace mistreatment of clinicians even before the pandemic. In the extraordinarily stressful environment we are currently experiencing, with people feeling exhausted and emotionally threadbare on some level, the problem appears to be growing.
We also predicted that the burden of mistreatment would not borne be equally. It has often been said that we are all in the same storm but in different boats – some of us are riding out the storm in comfortable ocean liners, while others are paddling in canoes without life jackets. What we are learning, though, is that we are not in fact experiencing the same storm. For example, the increasing intolerance and erosion of public civility we have seen in recent years might show up as minor annoyances for some of us, and actual threats of violence for others depending in large part on our gender and racialized identities. Our relationship to privilege and oppression affects our experiences, creating protections or additional burdens, so when studying clinician occupational well-being, it seemed important to consider how these disparities play out in the workplace.
Dr. Vashi[/caption]
Dr. Neelam Vashi MD
Director of the Boston University Center for Ethnic Skin
Dermatologist at Boston Medical Center, and
[caption id="attachment_59079" align="alignleft" width="100"]
Dr. De La Garza[/caption]
Dr. Henriette De La Garza MD
Research fellow
Boston University School of Medicine
MedicalResearch.com: What is the background for this study?
Response: The COVID-19 pandemic abruptly shifted many of our daily activities to an online world, dramatically increasing the use of electronic devices. Although visible light exposure from screens is small compared with the amount of exposure from the sun, there is concern about the long-term effects of excessive screen time. Recent studies have demonstrated that exposure to light emitted from electronic devices, even for as little as 1 hour, may cause reactive oxygen species generation, apoptosis, collagen degradation, and necrosis of skin cells. Visible light increases tyrosinase activity and induces immediate erythema in light-skinned individuals and long-lasting pigmentation in dark-skinned individuals. In recent years, tinted sunscreens have been rising in popularity because they are an effective and convenient way to protect against high-energy visible light while providing cosmetic benefits. The purpose of this analysis was to study current available options and product factors that may influence consumer preference when choosing a tinted sunscreen so dermatologists can improve their familiarity with available products and tailor their recommendations to patients with all skin tones.
